Conference looks at HIV drug resistance.
Chang
H E
HE
D000998:Antiviral Agents / Q000494:pharmacology* / Q000627:therapeutic use; D018791:CD4 Lymphocyte Count; D002219:Carbamates; D004352:Drug Resistance, Microbial; D005663:Furans; D006678:HIV / Q000187:drug effects*; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy; D017320:HIV Protease Inhibitors / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D019469:Indinavir; D007546:Isoquinolines / Q000494:pharmacology / Q000627:therapeutic use; D019259:Lamivudine; D011725:Pyridines / Q000494:pharmacology / Q000627:therapeutic use; D011804:Quinolines / Q000494:pharmacology / Q000627:therapeutic use; D019438:Ritonavir; D019258:Saquinavir; D013449:Sulfonamides / Q000494:pharmacology / Q000627:therapeutic use; D013844:Thiazoles / Q000494:pharmacology / Q000627:therapeutic use; D014633:Valine / Q000494:pharmacology / Q000627:therapeutic use; D014766:Viremia; D016047:Zalcitabine / Q000031:analogs & derivatives / Q000494:pharmacology / Q000627:therapeutic use; D015215:Zidovudine / Q000494:pharmacology / Q000627:therapeutic use
D000998:Antiviral Agents; D002219:Carbamates; D005663:Furans; D017320:HIV Protease Inhibitors; D007546:Isoquinolines; D011725:Pyridines; D011804:Quinolines; D013449:Sulfonamides; D013844:Thiazoles; D019259:Lamivudine; D015215:Zidovudine; C095108:amprenavir; D019469:Indinavir; D016047:Zalcitabine; D014633:Valine; D019258:Saquinavir; D019438:Ritonavir